Astatine

Think CARA visits single digits

Short
NASDAQ:CARA   Cara Therapeutics, Inc.
Seems like we are the beginning stages of an IHS failure

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.